Medacta Group SA

Medacta unveils the extended enhancements to its Hip Revision Platform

Medacta Hosts Inaugural Capital Markets Day, Showcasing Responsible Innovation and Effective Growth Strategy

Medacta Group SA reports revenue growth of 14.3% at constant currency and adjusted EBITDA margin 26.9%, or 28.1% at constant currency in 1H 2024.

Medacta NextAR Rod Optimizer, a Disruptive Technology Redefining Rod Management in Spine Surgery, wins the 2024 Spine Technology Award from Orthopedics This Week

Medacta Introduces a Simplified Approach for the M-ARS ACL Technique at the AGA Congress 2024, Mimicking the Native Ligament Footprint with an Optimized Surgical Flow

Medacta Enters Partnership with THINK Surgical for Robotic Total Knee Arthroplasty Solution